We hereby inform you that in terms of Company''s Code for Prevention of Insider Trading framed under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company will remain closed for all Insiders, Designated Persons and their Immediate Relatives, with effect from 01st July, 2024 for the purpose of consideration of Unaudited Financial Results for the Quarter and Three Months ended 30th June, 2024 and shall open 48 hours after it become generally available. Kindly take the same on records.

pdf

Parnax Lab Ltd.

04 Jun 2024

123.25

-0.04%

AGM

PARNAX LAB LTD. - 506128 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

BSE India

This is in furtherance to our letter dated June 04, 2024, with regards to Notice of the Postal Ballot of the Company, please find enclosed herewith a revised Postal Ballot Notice with detailed e-voting instructions. Kindly take the above information on your record.

pdf

Parnax Lab Ltd.

04 Jun 2024

123.25

-0.04%

Company Update

PARNAX LAB LTD. - 506128 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Kindly find enclosed herewith copies of a Newspaper Advertisement published today i.e. June 04, 2024, in Free Press Journal (English Daily) and Navshakti (Marathi Daily), Mumbai Editions, confirming dispatch of notice of Postal Ballot.

pdf

Parnax Lab Ltd.

04 Jun 2024

123.25

-0.04%

AGM

PARNAX LAB LTD. - 506128 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

BSE India

Please find enclosed herewith the Postal Ballot Notice, for seeking approval of Shareholders of the Company on the mentioned resolutions through remote E-Voting process only.

pdf

Parnax Lab Ltd.

31 May 2024, 12:00AM

123.25

-0.04%

Annual Report

Annual report for Parnax Lab Ltd. for FY-2024

None

pdf

Parnax Lab Ltd.

30 May 2024

123.25

-0.04%

Company Update

PARNAX LAB LTD. - 506128 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Kindly find attached herewith the Secretarial Compliance Report under Regulation 24A of SEBI (LODR), Regulations, 2015.

pdf

Parnax Lab Ltd.

30 May 2024

123.25

-0.04%

Result

PARNAX LAB LTD. - 506128 - Results-Audited Financial Results For The Quarter And Year Ended March …

BSE India

Kindly find enclosed therewith the Audited Standalone and Consolidated Financial Results for the Quarter and Year Ended March 31, 2024.

pdf

Parnax Lab Ltd.

30 May 2024

123.25

-0.04%

Board Meeting

PARNAX LAB LTD. - 506128 - Board Meeting Outcome for Board Meeting Outcome For Results-Audited Financial …

BSE India

Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Thursday, 30th May, 2024, at its Registered Office, the Board inter alia has transacted the following business: 1. Considered and Approved the Standalone & Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March, 2024, along with Auditor's Report thereon. 2. Declaration pursuant to Regulation 33(3)(d) as amended by the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015. (A declaration is attached herewith as Annexure-I).

pdf

Parnax Lab Ltd.

22 May 2024

123.25

-0.04%

Board Meeting

PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Board Meeting Intimation For The Meeting …

BSE India

PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of Listing Obligation and Disclosure Requirements, 2015, We hereby inform you that a meeting of the Board of Directors of the Company PARNAX LAB LIMITED is schedule to be held on Thursday, May 30, 2024, at the registered office of the Company, inter alia, to transact the following business: 1. To consider and approve Standalone and Consolidated Audited IND- AS Compliant Financial Results along with Auditor Report for the quarter (Q4) and Year ended 31st March, 2024, pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with the permission of the Chair. Kindly note that the approved results will be sent to you after the conclusion of the Board meeting

pdf

Is Parnax Lab Ltd. worth buying?

18 Votes:

Buy 72.22%

Sell 16.67%

Hold 11.11%